BlackRock Advisors’s Windtree Therapeutics Inc WINT Stock Holding History

BlackRock Advisors’s Portfolio WINT Stock Details WINT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$4K	Hold	2,806	–	–	﹤0.01%	3655
2016 Q3	$7K	Hold	2,806	–	–	﹤0.01%	3623
2016 Q2	$5K	Hold	2,806	–	–	﹤0.01%	3673
2016 Q1	$5K	Hold	2,806	–	–	﹤0.01%	3678
2015 Q4	$8K	Hold	2,806	–	–	﹤0.01%	3669
2015 Q3	$12K	Buy	2,806 +1,210	+76%	+$8.01K	﹤0.01%	3632
2015 Q2	$15K	Hold	1,596	–	–	﹤0.01%	3567
2015 Q1	$27K	Hold	1,596	–	–	﹤0.01%	3391
2014 Q4	$26K	Hold	1,596	–	–	﹤0.01%	3442
2014 Q3	$41K	Hold	1,596	–	–	﹤0.01%	3320
2014 Q2	$40K	Hold	1,596	–	–	﹤0.01%	3295
2014 Q1	$48K	Buy	1,596 +258	+19%	+$8.68K	﹤0.01%	3265
2013 Q4	$42K	Buy	1,338 +604	+82%	+$18.9K	﹤0.01%	3275
2013 Q3	$20K	Sell	734 -110	-13%	-$2.67K	﹤0.01%	3324
2013 Q2	$18K	Buy	+844	New	+$20.8K	﹤0.01%	3295

Other funds holding WINT

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

BlackRock Advisors's WINT Position: Q4 2016 in Review

BlackRock Advisors held its Windtree Therapeutics Inc (WINT) position steady in Q4 2016 at 2,806 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #3655.

BlackRock Advisors first reported a position in WINT in Q2 2013 and has held it in 15 quarters since. The position peaked at $48K in Q1 2014. 31 funds tracked by Wall St. Rank hold WINT as of Q4 2016.

BlackRock Advisors held 2,806 shares of Windtree Therapeutics Inc worth $4K as of Q4 2016.
BlackRock Advisors left its Windtree Therapeutics Inc share count unchanged in Q4 2016.
Windtree Therapeutics Inc made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3655 holding.
BlackRock Advisors first reported a position in Windtree Therapeutics Inc in Q2 2013 and has held it in 15 quarters since.
BlackRock Advisors's Windtree Therapeutics Inc position peaked at $48K in Q1 2014.
31 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.